COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 8th, 2018 • Editas Medicine, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 8th, 2018 Company Industry JurisdictionThis COLLABORATION AND LICENSE AGREEMENT (this “Agreement”), effective as of May 26, 2015 (the “Effective Date”), is made by and between Editas Medicine, Inc., a Delaware corporation, having a principal place of business at 300 Third Street, First Floor, Cambridge, MA 02142 (“Editas”), and Juno Therapeutics, Inc., a Delaware corporation, having a place of business at 307 Westlake Avenue North, Suite 300, Seattle, WA 98109 (“Juno”).